Parallel sessions
Parallel Session I – June 5th, 13:10 – 14:00
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
13:10-13:25 |
OPI.A1 |
Using school absenteeism to predict acute respiratory infection rates in primary school-aged children |
Alexandra-Maria Rus |
|
13:25-13:40 |
OPI.A2
|
Adherence to cardiovascular disease medication in chronic kidney disease patients: a systematic review and meta-analysis |
Siddhi Hegde |
|
13:40-13:55 |
OPI.A3
|
Tea consumption, genetic predisposition and cardiovascular mortality in a patient population: the Alpha Omega Cohort |
Cristina Perez Hernandez |
|
|
Characteristics and determinants of daily glucose patterns in normal glucose metabolism, Machine Learning Assisted Classification (this presentation will take place on Friday, 6 June, 11:00 – 12:30, during Parallel III.D session) |
Jort Fris
| |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
13:10-13:25 |
OPI.B1
|
Impact of study design specifications on effect size heterogeneity of myocarditis risk following COVID-19 vaccination: A systematic review, meta-analysis and meta-regression |
Trang Tu |
|
13:25-13:40 |
OPI.B2
|
Risk factors in the first 1000 days of life associated with childhood obesity: a systematic review and risk factor quality assessment |
Arwen Kamphuis |
|
13:40-13:55 |
OPI.B3
|
The carbon footprint of clinical trials: a systematic review and meta-analysis |
Mitra Nekouei Shahraki |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
13:10-13:25 |
OPI.C1
|
The associations between sleep health and coagulation factors in population-based cohort studies |
Jihee Han |
|
13:25-13:40 |
OPI.C2
|
Gut microbiome connections with habitual diet and liver health: from 10K cohort |
Keyong Deng |
|
13:40-13:55 |
OPI.C3
|
Uncovering proteomic and metabolomic pathways linking healthy dietary patterns to cardiometabolic disease prevention |
Jihee Han |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
13:10-13:25 |
OPI.D1
|
Effectiveness of Omicron JN.1 vaccination against SARS-CoV-2 infection in a prospective cohort study in the Netherlands, September 2024 to February 2025 |
Anne Huiberts |
|
13:25-13:40 |
OPI.D2
|
Post-COVID Network Netherlands |
Miek De Dreu |
|
13:40-13:55 |
OPI.D3
|
Multi-cancer early detection screening: the need for an ethical and epidemiological exploration |
Maria Siermann |
Parallel Session II – June 5th, 15:45 – 17:00
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
15:45-16:00 |
OPII.A1
|
Exploring optimism in sample size calculations of clinical trial protocols |
Marieke Jansen |
|
16:00-16:15 |
OPII.A2
|
Study protocol for the DISTINCT trial: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCement |
Ruben Kok |
|
16:15-16:30 |
OPII.A3
|
Sex differences in vitamin K antagonist treatment in patients with mechanical heart valves – a nationwide linked-data study |
Eva Kempers |
|
16:30-16:45 |
OPII.A4
|
Medical Risk Classification For Severe Covid-19 Based On Chronic Medical Conditions: A Comparative Analysis |
Ilse Westerhof |
|
16:45-17:00 |
OPII.A5
|
The association between intrinsic capacity and functional ability in older adults – exploring the role of the physical environment |
Jaro Govaerts |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
15:45-16:00 |
OPII.B1
|
Introduction (Letting the Data Speak: Machine Learning for Modern Epidemiology) |
Marcel Haas
|
|
16:00-16:15 |
OPII.B2
|
Artificial intelligence can improve standardisation of lung nodule classification in lung cancer screening |
Harriet Louise Lancaster |
|
16:15-16:30
|
OPII.B3
|
Notification of locoregional breast cancer recurrence based on pathology reports: a nationwide validation study with a national cancer registry |
Linda De Munck |
|
16:30-16:45
|
OPII.B4
|
From Plate to Health State: Metabolomic signatures for four diet scores and incidence of Cardiovascular Disease and Diabetes Mellitus. The Doetinchem Cohort Study. |
Annelot Smit |
|
16:45-17:00
|
OPII.B5
|
Understanding eHealth Acceptance Among COPD Patients: An Innovative Machine Learning Approach to Identify Interaction Patterns and Prototypes |
Le Nguyen |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
15:45-16:00 |
OPII.C1
|
Introduction (Causality, what’s in a name) |
Olaf Dekkers |
|
16:00-16:15 |
OPII.C2
|
Prediction of major bleeding or mortality with and without platelet transfusion in preterm infants: model development and validation |
Hilde van der Staaij |
|
16:15-16:30
|
OPII.C3
|
Metabolite profiling identifies biomarkers associated with key Alzheimer’s disease progression protein biomarkers in the Rotterdam Study |
Midas Kuilman |
|
16:30-16:45
|
OPII.C4
|
Smoking and stress: triangulation of evidence from causally informative methods |
Tessa Zonneveld |
|
16:45-17:00
|
OPII.C5
|
A Target Trial Emulation with an Extension to Subgroups: an Example for Relapsing-Remitting Multiple Sclerosis |
Stefan Verweij |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
15:45-16:00 |
OPII.D1
|
Introduction (What are predictions good for?) |
Nan van Geloven |
|
16:00-16:15 |
OPII.D2 |
Incorporating longitudinal variability in prediction models: a comparison of machine learning and logistic regression |
Liza De Groot |
|
16:15-16:30 |
OPII.D3 |
Risk prediction for individual patients and the pitfalls of selecting an optimal prediction model – do not judge a model by its AUC |
Jan Willem van Dalen |
|
16:30-16:45 |
OPII.D4 |
Utility of glucose, lipid and kidney function trajectory measures for incident cardiovascular disease risk prediction for people with type 2 diabetes |
Peter Harms |
|
16:45-17:00 |
OPII.D5 |
Using additional risk factors in the formation of cervical (pre) malignancy risk profiles for the triage of high risk human papilloma virus positive women in screening |
Marleen Boonstra |
Parallel Session III – June 6th, 11:00 – 12:30
Parallel III.A |
Survival (Location: The Imperial)Chair: Hein Putter & Jihee Han |
| |
|
Time |
Code |
Title |
Presenter |
|
11:00-11:15 |
OPIII.A1
|
Introduction (Selection effects of the Cox model and the hazard ratio crisis) |
Hein Putter |
|
11:15-11:30 |
OPIII.A2
|
Improved mortality prediction by including health- and lifestyle-related factors besides metabolomics-based MetaboHealth |
Marian Beekman |
|
11:30-11:45 |
OPIII.A3
|
Health literacy and multimorbidity: a multistate model for survival analysis following participants from a dutch cohort study |
Fernando Gregorio Linares Jimenez |
|
11:45-12:00 |
OPIII.A4
|
Epidemiology of pulmonary hypertension following pulmonary embolism in the Netherlands |
Qingui Chen |
|
12:00-12:15 |
OPIII.A5
|
Comparative analysis of 14 prediction models for burn-related mortality in specialized Dutch burn centres; an independent external validation study |
Anouk Pijpe |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
11:00-11:15 |
OPIII.B1
|
Introduction (Longitudinal data) |
Saskia le Cessie |
|
11:15-11:30 |
OPIII.B2
|
Early-Life Risk Prediction of Childhood Asthma: An Individual Participant Data Meta-Analysis of 135000 Children |
Tarik Karramass |
|
11:30-11:45 |
OPIII.B3
|
Bidirectional causal association between depression and new-onset atrial fibrillation among women and men |
Noluthando Ntlapo |
|
11:45-12:00 |
OPIII.B4
|
Longitudinal change in physical activity components among older community-dwelling adults. |
Bram Hoogerheide |
|
12:00-12:15 |
OPIII.B5
|
Association between body mass index, waist circumference, and (abdominal) obesity and sex- and age-specific cognitive function and decline – The Doetinchem Cohort Study |
Femke te Hoonte |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
11:00-11:15 |
OPIII.C1
|
Introduction (Where’s the value in real-world data?) |
Rolf Groenwold |
|
11:15-11:30 |
OPIII.C2
|
Impact of policy measures targeting benzodiazepine and benzodiazepine related drugs in Lithuania |
Tomas Lasys |
|
11:30-11:45 |
OPIII.C3
|
Sex differences in the use of blood pressure lowering therapy and blood pressure control |
Tessa Duk |
|
11:45-12:00 |
OPIII.C4
|
Development of a post-PCI risk score for target lesion revascularization during one-year follow-up using real-world data from the Netherlands Heart Registration. |
Lineke Derks |
|
12:00-12:15 |
OPIII.C5
|
Added value of denominator data for interpretation of epidemiological trends in weekly laboratory surveillance of respiratory infections for the 2023/2024 and 2024/2025 seasons |
Maxime Hartwig |
|
|
| |
|
Time |
Code |
Title |
Presenter |
|
11:00-11:15 |
OPIII.D1
|
Introduction (Pathways from Adiposity to Disease: Design and Aims of the Netherlands Epidemiology of Obesity (NEO) study) |
Jeroen van der Velde |
|
11:15-11:30 |
OPIII.D4
|
Age at menopause: risk and protective factors, a study among women participating in a long-running cohort – the Doetinchem Cohort Study |
Isabel Pieterse |
|
11:30-11:45 |
OPIII.D5
|
Timing of Moderate-to-Vigorous Physical Activity and the Risk of Developing Type 2 Diabetes Mellitus: Evidence from UK Biobank and NHANES |
Qiuyu Feng |
|
11:45-12:00 |
OPIII.D3
|
Divergent temporal trends in diagnosed cardiometabolic diseases: A birth cohort and Age-Period-Cohort effect analysis in UK Biobank |
Denghui Hu |
|
12:00-12:15 |
OPIII.D2
|
Characteristics and determinants of daily glucose patterns in normal glucose metabolism, Machine Learning Assisted Classification (this presentation is part of the Student award) |
Jort Fris |